Indivior (INVVY) Short Interest Ratio & Short Volume → [Shocking] Elon Musk’s Plan To End Banks (From Crypto 101 Media) (Ad) Free INVVY Stock Alerts $21.85 -0.40 (-1.82%) (As of 06/9/2023) Add Compare Share Share Short InterestStock AnalysisHeadlinesStock AnalysisHeadlines Indivior Short Interest DataCurrent Short Volume23,500 sharesPrevious Short Volume13,100 sharesChange Vs. Previous Month+79.39%Dollar Volume Sold Short$528,750.00Short Interest Ratio / Days to Cover2.3Last Record DateMay 31, 2023Outstanding Shares137,880,000 sharesPercentage of Shares Shorted0.02%Today's Trading Volume8,100 sharesAverage Trading Volume3,825 sharesToday's Volume Vs. Average212% Short Selling Indivior ? Sign up to receive the latest short interest report for Indivior and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINVVY Short Interest Over TimeINVVY Days to Cover Over TimeINVVY Percentage of Float Shorted Over Time Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Indivior Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/202323,500 shares $528,750.00 +79.4%N/A2.3 $22.50 5/15/202313,100 shares $346,495.00 -49.6%N/A3 $26.45 4/30/202326,000 shares $702,000.00 +3.2%N/A4.8 $27.00 4/15/202325,200 shares $554,400.00 -27.8%N/A3.2 $22.00 3/31/202334,900 shares $813,170.00 +93.9%N/A4.1 $23.30 3/15/202318,000 shares $355,680.00 +190.3%N/A1.9 $19.76 Get the Latest News and Ratings for INVVY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Indivior and its competitors with MarketBeat's FREE daily newsletter. 2/28/20236,200 shares $120,652.00 +1,140.0%N/A0.7 $19.46 2/15/2023500 shares $12,221.00 -90.4%N/A0.1 $24.44 1/31/20235,200 shares $126,932.00 -33.3%N/A1.4 $24.41 1/15/20237,800 shares $187,200.00 -20.4%N/A1.5 $24.00 12/30/20229,800 shares $221,480.00 -14.8%N/A4.1 $22.60 12/15/202211,500 shares $257,830.00 -25.8%N/A4.6 $22.42 11/30/202215,500 shares $312,170.00 +3.3%N/A4.2 $20.14 11/15/202215,000 shares $316,500.00 +2.0%N/A4.2 $21.10 10/31/202214,700 shares $281,065.47 -22.6%N/A6.1 $19.12 10/15/202219,000 shares $345,800.00 -14.0%N/A2.6 $18.20 9/30/202222,100 shares $353,597.79 +43.5%N/A2 $16.00 9/15/202215,400 shares $262,109.54 +7.7%N/A3.3 $17.02 8/31/202214,300 shares $239,668.00 +15.3%N/A2.7 $16.76 8/15/202212,400 shares $235,228.00 +1,027.3%N/A1.5 $18.97 7/31/20221,100 shares $21,296.00 -21.4%N/A0.7 $19.36 7/15/20221,400 shares $25,200.00 -65.9%N/A0.3 $18.00 6/30/20224,100 shares $77,982.00 -46.8%N/A1.6 $19.02 6/15/20227,700 shares $131,285.00 -15.4%N/A1.8 $17.05 5/31/20229,100 shares $194,558.00 -9.0%N/A7.6 $21.38 5/15/202210,000 shares $181,900.00 -36.7%N/A2.3 $18.19 4/30/202215,800 shares $324,234.96 +38.6%N/A3.9 $20.52 4/15/202211,400 shares $245,101.14 No ChangeN/A0.4 $21.50 3/15/2022200 shares $3,484.00 +100.0%N/A0.1 $17.42 2/28/2022100 shares $1,862.18 -94.7%N/A0 $18.62 2/15/20221,900 shares $29,184.00 No ChangeN/A0.4 $15.36 1/15/2022200 shares $3,098.00 No ChangeN/A0 $15.49 6/15/20211,100 shares $12,166.00 -35.3%N/A0.2 $11.06 5/28/20211,700 shares $18,700.00 -34.6%N/A0.8 $11.00 5/14/20212,600 shares $26,806.00 -7.1%N/A0.4 $10.31 4/30/20212,800 shares $27,507.20 -82.3%N/A0.5 $9.82 4/15/202115,800 shares $145,454.80 -10.7%N/A2.4 $9.21 3/31/202117,700 shares $147,972.00 +8.6%N/A1.4 $8.36 3/15/202116,300 shares $134,475.00 -2.4%N/A1.9 $8.25 2/26/202116,700 shares $151,135.00 +79.6%N/A1.5 $9.05SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. INVVY Short Interest - Frequently Asked Questions What is Indivior's current short interest? Short interest is the volume of Indivior shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 23,500 shares of INVVY short. Learn More on Indivior's current short interest. What is a good short interest ratio for Indivior? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INVVY shares currently have a short interest ratio of 2.0. Learn More on Indivior's short interest ratio. Is Indivior's short interest increasing or decreasing? Indivior saw a increase in short interest in May. As of May 31st, there was short interest totaling 23,500 shares, an increase of 79.4% from the previous total of 13,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Indivior's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Indivior: IDEAYA Biosciences, Inc. (14.29%), Arrowhead Pharmaceuticals, Inc. (7.16%), HUTCHMED (China) Limited (0.29%), Amicus Therapeutics, Inc. (11.00%), Xenon Pharmaceuticals Inc. (3.66%), Bausch Health Companies Inc. (6.31%), ACADIA Pharmaceuticals Inc. (6.80%), MoonLake Immunotherapeutics (16.21%), Axsome Therapeutics, Inc. (16.15%), MorphoSys AG (1.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.00 billion), Suncor Energy Inc. ($2.98 billion), Charter Communications, Inc. ($2.88 billion), Occidental Petroleum Co. ($2.79 billion), Moderna, Inc. ($2.39 billion), Snowflake Inc. ($2.38 billion), Coinbase Global, Inc. ($2.22 billion), Palantir Technologies Inc. ($2.18 billion), T. Rowe Price Group, Inc. ($2.03 billion), and Verisk Analytics, Inc. ($2.02 billion). View all of the most shorted stocks. What does it mean to sell short Indivior stock? Short selling INVVY is an investing strategy that aims to generate trading profit from Indivior as its price is falling. INVVY shares are trading down $0.40 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Indivior? A short squeeze for Indivior occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INVVY, which in turn drives the price of the stock up even further. How often is Indivior's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INVVY, twice per month. The most recent reporting period available is May, 31 2023. More Short Interest Resources from MarketBeat Related Companies: IDEAYA Biosciences Short Squeeze Arrowhead Pharmaceuticals Short Squeeze HUTCHMED Short Squeeze Amicus Therapeutics Short Squeeze Xenon Pharmaceuticals Short Squeeze Bausch Health Companies Short Squeeze ACADIA Pharmaceuticals Short Squeeze MoonLake Immunotherapeutics Short Squeeze Axsome Therapeutics Short Squeeze MorphoSys Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:INVVY) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryThe #1 Crypto for 2024InvestorPlace